Opthea Appoints Parisa Zamiri And Tom Reilly Respectively As Chief Medical Officer And Chief Financial Officer, As The Company Continues To Prepare For The Sozinibercept Phase 3 Topline Data Readouts Of COAST Anticipated In Early Q2 Calendar Year 2025 And ShORe In Mid Calendar Year 2025
Author: Benzinga Newsdesk | October 08, 2024 07:12am